mike doustdar - Search News

News

Novo Nordisk appoints Mike Doustdar

Fast Company on MSN · 3d

NVO stock: Why did Novo Nordisk shares drop 20% today—and who is Maziar Mike Doustdar?

The GLP-1 weight-loss drug giant just cut its investor guidance for 2025. Could the boom be over? Health-related stocks are not having a good day. First, America’s largest health insurance provider, UnitedHealth Group (NYSE: UNH),

PharmExec · 2d

Novo Nordisk Names Maziar Mike Doustdar as President and Chief Executive Officer

Effective August 7, 2025, Maziar Mike Doustdar will succeed Lars Fruergaard Jørgensen as Novo Nordisk president and chief executive officer (CEO). Jørgensen will step down from his current role serving as president and CEO on the same day Doustdar is expected to take over.

Reuters on MSN · 3d

Obesity drugmaker Novo Nordisk picks Maziar Mike Doustdar as new CEO, shares plunge

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug Wegovy is falling behind in a race it started.

2don MSN

Wegovy maker Novo's profit warning triggers $70 billion share rout

Investors wiped $70 billion off Novo Nordisk's market value on Tuesday after the maker of weight-loss drug Wegovy issued a ...

Contract Pharma2d

Novo Nordisk Appoints New President & CEO

Novo Nordisk has appointed Maziar Mike Doustdar as President and CEO, effective August 7, 2025. Doustdar succeeds Lars ...

3don MSN

Novo Lifer Takes Job of Reviving Europe’s Weight-Loss Superstar

Maziar Mike Doustdar spent more than three decades quietly climbing the ranks of Novo Nordisk A/S, from office clerk through ...

Pharma Industry Shaken: New Leadership and Tariff Challenges

Novo Nordisk's new CEO, Maziar Mike Doustdar, faces challenges in reviving waning sales and shares in the weight-loss drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results